Article
Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer
29 Jan 2019
Abstract excerpt
FAM64A, a marker of cell proliferation, has been investigated as a potential biomarker in several cancers. In the present study, we examined the value of FAM64A expression in the diagnosis and prognosis of pancreatic cancer through bioinformatics analysis of data obtained from The Cancer Genome Atlas (TCGA) database. The diagnostic value of FAM64A expression in pancreatic cancer tissue was deteremined through...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
